Survey: Despite Similar Levels of Vaccine Hesitancy, White People More Likely to Be Vaccinated Than Black People

New nationwide survey by Tufts University researchers finds those most hesitant are younger, less educated and more likely to trust former President Donald Trump; also finds racial divide in access to vaccine
Tufts University
18-May-2021 12:10 PM EDT, by Tufts University

Newswise — White people are more likely to have been vaccinated than Black people despite similar levels of vaccine hesitancy, or saying they are very unlikely to get a vaccine. Therefore, access to vaccines and other factors could be limiting vaccination efforts, according to a new, nationally representative study from the Tufts University Research Group on Equity in Health, Wealth and Civic Engagement.

Compared to other adult Americans, vaccine-hesitant people are younger, have less education and are more likely to trust former President Donald Trump. The study indicates that vaccine-hesitancy and access are both limiting factors in overall vaccination rates, and that these factors differ by race.

About 17 percent of the U.S. adult population currently say they are “very unlikely” to get a vaccination for COVID-19, according to the researchers.

This nationally representative survey by Ipsos, using its KnowledgePanel, for the Tufts research group was fielded online between April 23 and May 3, 2021 and had 1,449 respondents.

Major findings include:

  • Sixty percent of respondents say they have already received the COVID-19 vaccine. This is similar to the CDC’s estimate of 57.4% for the adult population (as of May 7).
  • Among those not already vaccinated, 28.5% say they plan to get the vaccine and 39.5% say they are very unlikely to, with the rest unsure. The fact that nearly 40% of those not yet vaccinated are very unlikely to get the vaccine has important implications for public health efforts.

  • People who say that they are somewhat or very unlikely to get vaccinated give a wide array of reasons, of which the most common are concern about long-term effects (28%) and a belief that the issue has been politicized (19%). Of those who say they are very unlikely to vaccinate, 24% say that they believe they had COVID-19 at some point or else once tested positive for the virus.
  • Vaccine hesitancy varies by race and ethnicity. White respondents and African American respondents are about equally hesitant, with about 18-19% indicating that they are “very unlikely” to take the vaccine. Hispanic and Asian respondents are less likely to say this.
  • Older people are more likely to be vaccinated and less likely to be hesitant. Eighty-two percent of people 75 and older report being vaccinated. Younger adults (18-35) are the most hesitant.
  • Levels of vaccination rise, and vaccine hesitancy falls, with education. Adults with a master’s degree or higher are almost twice as likely to be vaccinated as those with a high school diploma or less.
  • When it comes to who people trust to provide reliable information about COVID-19, the largest number of people say they trust doctors and official health authorities, followed by President Joe Biden. Among media outlets, local television stations and newspapers are most trusted, and Fox News is least trusted (14%). Eighteen percent trust Trump. Three of these sources of information associations with vaccine status: doctors, government websites, and Trump. Of those who trust their doctors or government websites (such as the CDC) “completely,” 86-87% are already vaccinated and less than 2% say they are very unlikely to vaccinate. Of those who say they trust Trump completely, 34% are vaccinated and 48.5% are very unlikely to vaccinate.

“Our finding that white people are more likely to have been vaccinated than Black people, despite similar levels of vaccine hesitancy, illustrates critical issues around vaccine equity,” said Jennifer Allen, a professor of community health in the School of Arts and Sciences at Tufts University and an expert on vaccine hesitancy. “Making the vaccine easily accessible in communities that have experienced a disproportionate burden of COVID infections and deaths is vital. Without this, inequities will be made worse.

“Offering mobile clinics to reach those who are amenable to taking the vaccine is critical,” she added. “In some localities, financial and other forms of incentives are being offered for those who are not opposed to vaccination, but who may need a nudge to get vaccinated. These are the types of new approaches that are sorely needed at this point to get as many people vaccinated as possible.”

“Much work remains to be done to achieve herd immunity in the U.S., especially now that the COVID-19 variants circulating across the country merit vaccination rates of at least 80%,” said Tom Stopka, an associate professor of public health and community medicine  at Tufts University School of Medicine and infectious disease epidemiologist.  “Innovative public health interventions are needed to help increase vaccination coverage broadly, with a particular focus on younger people, communities of color, and specific political groups that are at higher risk for acquiring and transmitting the virus.”

Tufts University’s Research Group on Equity in Health, Wealth and Civic Engagement was established in 2019 as part of a strategic effort to use resources and expertise across the university to address major global issues. It brings together researchers from across the university to discuss and investigate aspects of equity and inequity in the United States and the world. The research has been funded by Tufts University’s Office of the Vice Provost, the Tisch College of Civic Life at Tufts, the Tufts Data Intensive Science Institute and Tufts Clinical and Translational Science Institute.

The group’s principal investigators are Peter Levine, associate dean for academic affairs and Lincoln Filene Professor of Citizenship & Public Affairs at the Tisch College of Civic Life at Tufts; Allen; and Stopka. Other members of the group can be found here.









Filters close

Showing results

110 of 5863
Released: 24-Jun-2021 6:05 AM EDT
Longest known SARS-CoV-2 infection of nearly 300 days successfully treated with new therapy
University of Bristol

An immunocompromised individual with the longest known PCR confirmed case of SARS-CoV-2 infection, lasting more than 290 days, has been successfully treated with two investigational monoclonal antibodies (laboratory engineered antibodies). Clinicians and researchers from the University of Bristol and North Bristol NHS Trust (NBT) worked closely to assess and treat the infection and want to highlight the urgent need for improved access to treatments for such people with persistent SARS-CoV-2 infection.

Released: 23-Jun-2021 3:55 PM EDT
Cooperative Extension grant aims to vaccinate NYS’ vulnerable
Cornell University

A two-year, $200,000 grant from the USDA and the Extension Foundation to Cornell University researchers aims to help promote vaccine confidence and uptake in vulnerable communities in eight New York counties, both upstate and downstate.

Released: 23-Jun-2021 12:10 PM EDT
Phone swabs can accurately detect COVID-19
University College London

An accurate, non-invasive, and low-cost method of testing for COVID-19 using samples taken from the screens of mobile phones has been developed by a team led by UCL researchers at Diagnosis Biotech.

Newswise: NIH study suggests COVID-19 prevalence far exceeded early pandemic cases
Released: 23-Jun-2021 11:35 AM EDT
NIH study suggests COVID-19 prevalence far exceeded early pandemic cases
National Institute of Biomedical Imaging and Bioengineering

In a new study, NIH researchers report that the prevalence of COVID-19 in the United States during spring and summer of 2020 far exceeded the known number of cases and that infection affected the country unevenly.

Released: 23-Jun-2021 11:25 AM EDT
Half of young adults with covid-19 have persistent symptoms 6 months after
University of Bergen

A paper published in the prestigious journal Nature Medicine on long-COVID, describes persistent symptoms six months after acute COVID-19, even in young home isolated people.

Newswise:Video Embedded covid-19-vaccine-hesitancy-dr-vin-gupta-narrates-new-american-thoracic-society-video
Released: 23-Jun-2021 9:40 AM EDT
COVID-19 Vaccine Hesitancy: Dr. Vin Gupta Narrates New American Thoracic Society Video
American Thoracic Society (ATS)

The American Thoracic Society rolls out a new video to address vaccine hesitancy and answer common questions amid the COVID-19 pandemic.

18-Jun-2021 11:00 AM EDT
Had COVID-19? One Vaccine Dose Enough; Boosters For All, Study Says
American Chemical Society (ACS)

A new study in ACS Nano supports increasing evidence that people who had COVID-19 need only one vaccine dose, and that boosters could be necessary for everyone in the future.

Released: 22-Jun-2021 5:10 PM EDT
Tecnología de inteligencia artificial y ECG puede rápidamente descartar infección por COVID-19
Mayo Clinic

La inteligencia artificial puede ofrecer un manera de determinar con exactitud que una persona no está infectada con la COVID-19. Un estudio internacional y retrospectivo descubrió que la infección por SARS-CoV-2, el virus que causa la COVID-19, provoca sutiles cambios eléctricos en el corazón. Un electrocardiograma (ECG) mediado por inteligencia artificial detecta estos cambios y puede servir como una prueba rápida y confiable para descartar la infección por COVID-19.

Released: 22-Jun-2021 4:45 PM EDT
Penn Medicine to Use $1M from City of Philadelphia for Additional Community Vaccination Clinics
Perelman School of Medicine at the University of Pennsylvania

Penn Medicine will continue its collaboration with the West and Southwest Philadelphia communities to operate a series of COVID-19 vaccine clinics in partnership with community organizations, faith-based institutions, restaurants, barbershops, and even professional sports teams thanks to $1 million in funding from the City of Philadelphia, in partnership with PMHCC.

Released: 22-Jun-2021 12:30 PM EDT
Political Variables Carried More Weight Than Healthcare in Government Response to COVID-19
Binghamton University, State University of New York

Political institutions such as the timing of elections and presidentialism had a larger influence on COVID-19 strategies than the institutions organizing national healthcare, according to a research team led by a professor at Binghamton University, State University of New York.

Showing results

110 of 5863